(Q43830902)

27 November 2017

title

Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphoma (English)

1 reference

27 November 2017

1 reference

4

1 reference

ORCID Public Data File 2021

27 November 2017

1 reference

author name string

Magagnoli M

1

1 reference

27 November 2017

Sarina B

2

1 reference

27 November 2017

Balzarotti M

3

1 reference

27 November 2017

Timofeeva I

5

1 reference

27 November 2017

Nozza A

6

1 reference

27 November 2017

Bertuzzi A

7

1 reference

27 November 2017

Siracusano L

8

1 reference

27 November 2017

Sinnone M

9

1 reference

27 November 2017

Santoro A

10

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Bone Marrow Transplantation

27 November 2017

published in

1 reference

27 November 2017

volume

28

1 reference

27 November 2017

issue

10

1 reference

27 November 2017

page(s)

923-927

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703265

27 November 2017

exact match

0 references

cites work

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

Chronic lymphocytic leukemia with an interfollicular architecture: avoiding diagnostic confusion with monocytoid B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

Stem cell mobilization in resistant or relapsed lymphoma: superior yield of progenitor cells following a salvage regimen comprising ifosphamide, etoposide and epirubicin compared to intermediate-dose cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703265

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1703265

1 reference

Dimensions Publication ID

27 November 2017

1043990970

0 references

1 reference